Eric Burak

Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II:  Discovery of an Orally Active GCP II Inhibitor

Pavel Majer, Paul Jackson, Greg Delahanty et al. · Journal of Medicinal Chemistry · 2003 · 108 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites

Stephen S. Hecht, Neil Trushin, Cheri A. Reid-Quinn et al. · Carcinogenesis · 1993 · 100 citations

Medicine, Pharmacokinetics, Pharmacology +10

Pharmacokinetics and Clinical Pharmacodynamics of the New Propofol Prodrug GPI 15715 in Volunteers: Retracted

J. Fechner, Harald Ihmsen, Dirk Hatterscheid et al. · Anesthesiology · 2003 · 74 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +13

The central nervous system effects, pharmacokinetics and safety of the NAALADase‐inhibitor GPI 5693

J. P. Van Der Post, Saco J. de Visser, Marieke L. de Kam et al. · British Journal of Clinical Pharmacology · 2005 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rates

M. Schywalsky, Harald Ihmsen, Alexander Tzabazis et al. · European Journal of Anaesthesiology · 2005 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +12